BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31678459)

  • 1. Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis.
    Bennett D; Bargagli E; Bianchi N; Landi C; Fossi A; Fui A; Sestini P; Refini RM; Rottoli P
    Respir Physiol Neurobiol; 2020 Feb; 273():103323. PubMed ID: 31678459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.
    Vercauteren IM; Verleden SE; McDonough JE; Vandermeulen E; Ruttens D; Lammertyn EJ; Bellon H; De Dycker E; Dooms C; Yserbyt J; Verleden GM; Vanaudenaerde BM; Wuyts WA
    Exp Lung Res; 2015; 41(8):459-65. PubMed ID: 26381718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Higher incidence of alveolar lymphocytes (AL) apoptosis in smokers depends on BCL-2 expression and specific response to tumor necrosis factor alpha (TNFalpha). Bronchoalveolar lavage (BAL) material analysis from selected interstitial lung diseases (ILD) and healthy controls].
    Kopiński P; Dyczek A; Chorostowska-Wynimko J; Marszałek A; Balicka-Slusarczyk B; Kubiszewska I; Szabłowska K; Półgesek E; Szpechciński A
    Przegl Lek; 2012; 69(10):731-6. PubMed ID: 23421021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases.
    Vogt S; Trendelenburg M; Tamm M; Stolz D; Hostettler KE; Osthoff M
    Front Immunol; 2020; 11():562564. PubMed ID: 33101280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP.
    Bennett D; Salvini M; Fui A; Cillis G; Cameli P; Mazzei MA; Fossi A; Refini RM; Rottoli P
    Inflammation; 2019 Apr; 42(2):463-470. PubMed ID: 30680696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Role of Bronchoalveolar Lavage in the Diagnosis of Idiopathic Pulmonary Fibrosis: An Investigation of the Relevance of the Protein Content].
    Schildge J; Frank J; Klar B
    Pneumologie; 2016 Jul; 70(7):435-41. PubMed ID: 27218212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
    Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC
    Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.
    Malli F; Bardaka F; Tsilioni I; Karetsi E; Gourgoulianis KI; Daniil Z
    Food Chem Toxicol; 2013 Nov; 61():160-3. PubMed ID: 23702326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis.
    Hou Z; Ye Q; Qiu M; Hao Y; Han J; Zeng H
    Respir Res; 2017 Sep; 18(1):170. PubMed ID: 28886713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis.
    Buendía-Roldán I; Ruiz V; Sierra P; Montes E; Ramírez R; Vega A; Salgado A; Vargas MH; Mejía M; Pardo A; Selman M
    PLoS One; 2016; 11(12):e0168552. PubMed ID: 27977812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calgranulin B (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis?
    Bargagli E; Olivieri C; Cintorino M; Refini RM; Bianchi N; Prasse A; Rottoli P
    Inflammation; 2011 Apr; 34(2):85-91. PubMed ID: 20422274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of osteopontin in smoking-related interstitial lung diseases.
    Prasse A; Stahl M; Schulz G; Kayser G; Wang L; Ask K; Yalcintepe J; Kirschbaum A; Bargagli E; Zissel G; Kolb M; Müller-Quernheim J; Weiss JM; Renkl AC
    Am J Pathol; 2009 May; 174(5):1683-91. PubMed ID: 19359522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.
    Rottoli P; Magi B; Perari MG; Liberatori S; Nikiforakis N; Bargagli E; Cianti R; Bini L; Pallini V
    Proteomics; 2005 Apr; 5(5):1423-30. PubMed ID: 15761959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.
    Rottoli P; Magi B; Cianti R; Bargagli E; Vagaggini C; Nikiforakis N; Pallini V; Bini L
    Proteomics; 2005 Jul; 5(10):2612-8. PubMed ID: 15924291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases.
    Przybylski G; Chorostowska-Wynimko J; Dyczek A; Wędrowska E; Jankowski M; Szpechciński A; Giżycka A; Golińska J; Kopiński P
    Pol Arch Med Wewn; 2015; 125(4):260-71. PubMed ID: 25697336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.